Dacikast

Daclatasvir Tablets 60 mg

Enquire NOW!




Description

Description

Dacikast

Composition: Daclatasvir 60mg

Therapeutic Class: Antiviral

Dacikast: Globally Available, Affordable Hepatitis C Medicine

Dacikast is available globally in 50-plus countries and is a well-tolerated, highly prescribed treatment for Hepatitis C.

Aprazer Healthcare: World-class Hepatology Medicines

Aprazer Healthcare manufactures international standard hepatology medicines, WHO-GMP certified, with assured therapeutic efficacy and safety.

What is Dacikast?

Dacikast consists of Daclatasvir, which is a direct-acting antiviral used in combination for chronic Hepatitis C treatment.

Uses of Dacikast

  • • Chronic Hepatitis C
  • • Against HCV strains 1–3 and others
  • • Used in combination therapy

How does Dacikast work?

  • • NS5A protein inhibition
  • • Inhibits viral replication, assembly, and release
  • • Blocks new viral cell formation

Benefits

  • • Rapidly reduces viral load
  • • Well tolerated, fewer side effects
  • • Shorter treatment duration
  • • Broad spectrum of activity (genotypes 1–3)
  • • Safe in HIV co-infections
  • • Can be used in compensated cirrhosis
  • • Can be used post-liver transplant
  • • Less risk of development of resistance

Common Side Effects

  • • Nausea
  • • Dizziness
  • • Headache
  • • Digestive issues
  • • Tiredness
  • • Diarrhea

Severe Side Effects

  • • Severe fall in RBC count when used with Ribavirin
  • • Anxiety, confusion
  • • Elevated liver enzymes, or hepatic decompensation in advanced-stage liver disorder
  • • Low heart rate when used with Amiodarone

Precautions

To be used cautiously in patients with:

  • • Heart disorders
  • • Decompensated liver cirrhosis
  • • HIV co-infections
  • • Drug interactions

Contraindications

  • • Not to be used if any previous allergy or hypersensitivity to Daclatasvir, or any excipients.
  • • Breastfeeding mothers
  • • Pregnant women

Warning

It is a prescription drug to be taken under medical supervision only.

Important Safety and Monitoring Information

Regular monitoring of hepatic functions, renal functions, cardiac functions, co-infections
Drug interactions – Ribavarin and Amiodarone
Not to be used as monotherapy for HCV infections.

Download Product PDF Attachment